These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31396315)

  • 1. Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
    Xie ZC; Wu HY; Ma FC; Dang YW; Peng ZG; Zhou HF; Chen G
    Am J Transl Res; 2019; 11(7):4010-4028. PubMed ID: 31396315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival-associated alternative splicing signatures in esophageal carcinoma.
    Mao S; Li Y; Lu Z; Che Y; Sun S; Huang J; Lei Y; Wang X; Liu C; Zheng S; Zang R; Li N; Li J; Sun N; He J
    Carcinogenesis; 2019 Mar; 40(1):121-130. PubMed ID: 30304323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.
    Gan W; Wang W; Li T; Zhang R; Hou Y; Lv S; Zeng Z; Yan Z; Yang M
    J Cancer; 2022; 13(5):1588-1602. PubMed ID: 35371307
    [No Abstract]   [Full Text] [Related]  

  • 4. Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma.
    Sun JR; Kong CF; Lou YN; Yu R; Qu XK; Jia LQ
    Front Genet; 2020; 11():796. PubMed ID: 32793288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Alternative Splicing Factors hnRNP G and Fox-2 in the Progression and Prognosis of Esophageal Cancer.
    Zheng Y; Niu X; Xue W; Li L; Geng Q; Fan Z; Zhao J
    Dis Markers; 2022; 2022():3043737. PubMed ID: 36466711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.
    Ye P; Yang Y; Zhang L; Zheng G
    Front Oncol; 2021; 11():658262. PubMed ID: 34676158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
    Xing L; Zhang X; Tong D
    DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
    Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG
    Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
    Li X; Wang Y; Li B; Ma W
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on the Potential Correlation Between
    Yao L; Zhong X; Huang G; Ma Q; Xu L; Xiao H; Guo X
    Front Cell Dev Biol; 2021; 9():730337. PubMed ID: 34778250
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Liu SP; Li XM; Liu DM; Xie SH; Zhang SB; Li Y; Xie ZF
    Front Oncol; 2022; 12():884448. PubMed ID: 35530327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
    Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H
    Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer.
    Liang Y; Song J; He D; Xia Y; Wu Y; Yin X; Liu J
    J Cell Physiol; 2019 Sep; 234(9):15836-15846. PubMed ID: 30740675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
    Gao L; He RQ; Huang ZG; Dang YW; Gu YY; Yan HB; Li SH; Chen G
    J Cancer; 2020; 11(6):1542-1554. PubMed ID: 32047561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
    Zong Z; Li H; Yi C; Ying H; Zhu Z; Wang H
    Front Oncol; 2018; 8():537. PubMed ID: 30524964
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer.
    Viet-Nhi NK; Minh Quan T; Cong Truc V; Anh Bich T; Hoang Nam P; Le NQK; Chen PY; Hung SH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer.
    Chai J; Lei Y; Xiang X; Ye J; Zhao H; Yi L
    Cancer Med; 2023 Mar; 12(6):7651-7666. PubMed ID: 36533709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing data.
    Zhang Y; Ma S; Niu Q; Han Y; Liu X; Jiang J; Chen S; Lin H
    BMC Genomics; 2020 Aug; 21(1):580. PubMed ID: 32831016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Front Oncol; 2020; 10():1257. PubMed ID: 32793502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.